CLOV vs NKE · rev $1.37B vs P/E 35, rev $46.31B
Clover Health Investments Corp (CLOV) versus Nike Inc (NKE) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Nike Inc (NKE) is a footwear & accessories company listed on US. It is led by John Donahoe.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported NKE revenue for 2025-05-31 was $46.31B. Net income was $3.22B. NKE currently screens at market cap $110.14B and trailing P/E 34.6.
CLOV currently screens at market cap $1.55B. NKE currently screens at market cap $110.14B and trailing P/E 34.6.
Not investment advice. Open the CLOV and NKE stock pages for the full models.
Not investment advice.